Title | Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Huang Y, Liu B, Sinha SC, Amin S, Gan L |
Journal | Mol Neurodegener |
Volume | 18 |
Issue | 1 |
Pagination | 79 |
Date Published | 2023 Nov 08 |
ISSN | 1750-1326 |
Keywords | DNA, Humans, Interferon Type I, Nervous System Diseases, Nucleotidyltransferases, Signal Transduction |
Abstract | DNA sensing is a pivotal component of the innate immune system that is responsible for detecting mislocalized DNA and triggering downstream inflammatory pathways. Among the DNA sensors, cyclic GMP-AMP synthase (cGAS) is a primary player in detecting cytosolic DNA, including foreign DNA from pathogens and self-DNA released during cellular damage, culminating in a type I interferon (IFN-I) response through stimulator of interferon genes (STING) activation. IFN-I cytokines are essential in mediating neuroinflammation, which is widely observed in CNS injury, neurodegeneration, and aging, suggesting an upstream role for the cGAS DNA sensing pathway. In this review, we summarize the latest developments on the cGAS-STING DNA-driven immune response in various neurological diseases and conditions. Our review covers the current understanding of the molecular mechanisms of cGAS activation and highlights cGAS-STING signaling in various cell types of central and peripheral nervous systems, such as resident brain immune cells, neurons, and glial cells. We then discuss the role of cGAS-STING signaling in different neurodegenerative conditions, including tauopathies, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, as well as aging and senescence. Finally, we lay out the current advancements in research and development of cGAS inhibitors and assess the prospects of targeting cGAS and STING as therapeutic strategies for a wide spectrum of neurological diseases. |
DOI | 10.1186/s13024-023-00672-x |
Alternate Journal | Mol Neurodegener |
PubMed ID | 37941028 |
PubMed Central ID | PMC10634099 |
Grant List | R01 AG074541 / AG / NIA NIH HHS / United States R01AG072758 / AG / NIA NIH HHS / United States R01AG074541 / AG / NIA NIH HHS / United States R01AG054214 / AG / NIA NIH HHS / United States |